Goldstone J
Am J Surg. 1978 Mar;135(3):385-8. doi: 10.1016/0002-9610(78)90071-5.
Removal of a massively enlarged spleen is a challenging surgical problem that is associated with higher death and complication rates than the removal of smaller spleens. Older age, serious and chronic primary diseases, and associated cardiopulmonary abnormalities contribute to the morbidity and mortality. Most patients with massive splenomegaly have been treated with corticosteroid and/or antineoplastic drugs, which impair wound healing, hemostatic function, and host resistance. Precise surgical technic is especially important in these cases because of the susceptibility to postoperative hemorrhage. Ligation of the splenic artery via the lesser peritoneal sac before mobilization of the spleen is associated with lower intraoperative transfusion requirements than when the spleen is mobilized before the splenic artery is ligated.
切除极度肿大的脾脏是一个具有挑战性的外科问题,与切除较小脾脏相比,其死亡率和并发症发生率更高。高龄、严重和慢性原发性疾病以及相关的心肺异常会导致发病和死亡。大多数脾肿大患者已接受皮质类固醇和/或抗肿瘤药物治疗,这些药物会损害伤口愈合、止血功能和宿主抵抗力。由于术后出血的易感性,精确的手术技术在这些病例中尤为重要。在游离脾脏之前通过小网膜囊结扎脾动脉与在结扎脾动脉之前游离脾脏相比,术中输血需求更低。